ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,163.67
-0.63%
Dow Jones
38,647.10
-0.17%
Gold vs US Dollar
2,305.37
0.12%
Brent Oil
82.115
0.17%
Bitcoin
66,744.72
-0.02%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Molecular Partners AG (MOLN) Share Price

MOLN Molecular Partners AG

5.74
-0.06 (-1.03%)
14 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Molecular Partners AG NASDAQ:MOLN NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.06 -1.03 5.74 5.48 6.78 6.145 5.54 6.1 398,460 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 7.04M -61.98M -1.7050 -14.78 916.12M
 Type  Size  Price  Time  Units 
 9 10 5.57 23:16:30 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore MOLN News
11/06/202415:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11/06/202406:00GLOBEMolecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
03/06/202422:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
01/06/202413:00GLOBEMolecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
17/05/202411:25EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
17/05/202411:25EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
17/05/202411:25EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
Period
Draw mode
Data Downloads for MOLN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Molecular Partners AG Articles